Low Vitamin D Status: Definition, Prevalence, Consequences, and Correction
Overview
Affiliations
Vitamin D is obtained from cutaneous production when 7-dehydrocholesterol is converted to vitamin D(3) (cholecalciferol) by ultraviolet B radiation or by oral intake of vitamin D(2) (ergocalciferol) and D(3). An individual's vitamin D status is best evaluated by measuring the circulating 25-hydroxyvitamin D (25(OH)D) concentration. Although controversy surrounds the definition of low vitamin D status, there is increasing agreement that the optimal circulating 25(OH)D level should be approximately 30 to 32 ng/mL or above. Using this definition, it has been estimated that approximately three-quarters of all adults in the United States have low levels. Low vitamin D status classically has skeletal consequences such as osteomalacia/rickets. More recently, associations between low vitamin D status and increased risk for various nonskeletal morbidities have been recognized; whether all of these associations are causally related to low vitamin D status remains to be determined. To achieve optimal vitamin D status, daily intakes of at least 1000 IU or more of vitamin D are required. The risk of toxicity with "high" amounts of vitamin D intake is low. Substantial between-individual variability exists in response to the same administered vitamin D dose. When to monitor 25(OH)D levels has received little attention. Supplementation with vitamin D(3) may be preferable to vitamin D(2).
Vitamin D deficiency in Scheuermann's disease is associated with increased adverse outcomes.
Chokshi S, Mudiganty S, Clement 3rd R, Accousti W SICOT J. 2024; 10:13.
PMID: 38568088 PMC: 10989516. DOI: 10.1051/sicotj/2024010.
Ulaganathan V, Lye M, Loh S, Yap Y, Kandiah M, Augundhooa D Nutrients. 2024; 16(3).
PMID: 38337681 PMC: 10857213. DOI: 10.3390/nu16030397.
Wang J, Sun G, Li F, Zhu Z, Sun L, Lv P Front Bioeng Biotechnol. 2024; 11:1326254.
PMID: 38188486 PMC: 10766695. DOI: 10.3389/fbioe.2023.1326254.
Effects of medical and surgical treatment on vitamin D levels in obesity.
Mejaddam A, Hoskuldsdottir G, Lener F, Wallenius V, Trimpou P, Fandriks L PLoS One. 2023; 18(12):e0292780.
PMID: 38134006 PMC: 10745143. DOI: 10.1371/journal.pone.0292780.
Wilde B, Hotaling J, Ishikawa H, Joyce C, Tashjian R, Chalmers P Arthrosc Sports Med Rehabil. 2023; 5(3):e695-e701.
PMID: 37388879 PMC: 10300579. DOI: 10.1016/j.asmr.2023.03.011.